Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin
Authors
Keywords
Non-small cell lung cancer, Cancer genomics, Biopsy, Breast cancer, Cancers and neoplasms, Genomics, Malignant tumors, Genome analysis
Journal
PLoS One
Volume 15, Issue 9, Pages e0237802
Publisher
Public Library of Science (PLoS)
Online
2020-09-26
DOI
10.1371/journal.pone.0237802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An overview of precision oncology basket and umbrella trials for clinicians
- (2020) Jay J. H. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
- (2019) Jason K. Sicklick et al. NATURE MEDICINE
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- LBA81_PRPhase II/III blood first assay screening trial (BFAST) in patients (pts) with treatment-naïve NSCLC: Initial results from the ALK+ cohort
- (2019) S M Gadgeel et al. ANNALS OF ONCOLOGY
- Towards precision oncology in advanced prostate cancer
- (2019) Sheng-Yu Ku et al. Nature Reviews Urology
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies
- (2018) Justin I. Odegaard et al. CLINICAL CANCER RESEARCH
- Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
- (2018) Travis A. Clark et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- IASLC Statement Paper: Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC)
- (2018) Christian Rolfo et al. Journal of Thoracic Oncology
- Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling
- (2018) Vincent Plagnol et al. PLoS One
- TARIBO Trial: Targeted Therapy with or without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery
- (2018) Elena Verzoni et al. TUMORI
- Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
- (2018) Matti Annala et al. Cancer Discovery
- TARIBO Trial: Targeted Therapy with or without Nephrectomy in Metastatic Renal Cell Carcinoma: Liquid Biopsy for Biomarkers Discovery
- (2018) Elena Verzoni et al. TUMORI JOURNAL
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
- (2018) Cheol-Kyu Park et al. Cancer Research and Treatment
- Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors
- (2018) Cathy Zhou et al. Journal of Hematology & Oncology
- Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib
- (2018) Maximilian J. Hochmair et al. Targeted Oncology
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer
- (2018) Charu Aggarwal et al. JAMA Oncology
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (2017) Mariam Jamal-Hanjani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liquid Biopsies for Cancer: Coming to a Patient near You
- (2017) Nithya Krishnamurthy et al. Journal of Clinical Medicine
- Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
- (2016) J. C. Thompson et al. CLINICAL CANCER RESEARCH
- Statistical Methods for Clinical Validation of Follow-On Companion Diagnostic Devices via an External Concordance Study
- (2016) Meijuan Li Statistics in Biopharmaceutical Research
- Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Intratumoral Heterogeneity of ALK-Rearranged and ALK/EGFR Coaltered Lung Adenocarcinoma
- (2015) Weijing Cai et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)
- (2014) Christos Chouaid et al. LUNG CANCER
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now